A drug used to treat Ebola has shown “very encouraging results” at cutting recovery times for coronavirus patients, according to a scientist leading the trials.
An international clinical trial, co-led by University College London (UCL) and the UK’s Medical Research Council, found the antiviral drug Remdesivir speeds up recovery from coronavirus by almost a third.
Abdel Babiker, professor of epidemiology and medical statistics at UCL, told BBC Radio 4’s Today programme: “These are very encouraging results from the first large-scale randomised trial to report on any treatment of COVID-19.”
He said the group of adults being treated in hospital for advanced coronavirus who received Remdesivir recovered “much faster” than the group that received a placebo.
Babiker said a similar trial of 237 adults in China that showed no benefits of the drug was “probably not large enough”.
That study concluded that